NFE2L2 polymorphisms, mortality, and metabolism in the general population
This study shows for the first time that NFE2L2 is associated with reduced risk of all-cause, cardiovascular and COPD mortality in humans.
Source: Physiological Genomics - Category: Genetics & Stem Cells Authors: Figarska, S. M., Vonk, J. M., Boezen, H. M. Tags: General Interest Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Chronic Obstructive Pulmonary | Genetics | Heart | Smokers | Study